Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2003
03/27/2003CA2459454A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003WO2002026732A1 Benzodiazepine derivative
03/26/2003EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
03/26/2003EP1295878A1 Novel pyrazinone derivatives
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294823A1 Double-spiro organic compounds and electroluminescent devices
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1212315B1 Novel chalcones
03/26/2003EP1212311B1 Chalcone coumarins
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1175420B1 Process for preparing n6-substituted deaza-adenosine derivatives
03/26/2003EP1159269B1 Anti-imflammatory indole derivatives
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1405162A C7 ester-substituted taxane
03/26/2003CN1405157A Novel diazo alcoholic antifungal compound and its salt
03/26/2003CN1103770C Quino xaline diones
03/26/2003CA2423902A1 Benzodiazepine derivative
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538144 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparation and use
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6538002 In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3. as antiinflammatory agents
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2254273C Preparation of substituted isoserine esters using metal alkoxides and .beta.-lactams
03/20/2003WO2003022843A1 Pyrazolyl-substituted thienyloxypyridines
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022836A1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022831A1 4-alkyl-substitute thienyloxy-pyridines
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022051A1 Herbicidal n-alkylsulfonamino derivatives
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002085819A3 Production of tertiary amines by reductive amination
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003US20030055272 Antileukemia and antitumor agents
03/20/2003US20030055266 Small molecule modulators of G protein-coupled receptors
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055087 As analgesic
03/20/2003US20030055084 Pharmaceutical compounds and methods of use thereof
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells
03/20/2003US20030055062 Heteroaryl urea neuropeptide Y Y5 receptor antagonists
03/20/2003US20030055057 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives
03/20/2003US20030055056 For use as antitumor and immune suppressive agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth
03/20/2003US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055033 Azetidine derivatives, their preparation and pharmaceutical compositions containing them
03/20/2003US20030054198 Image display device
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459445A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003CA2459360A1 4-alkyl-substitute thienyloxy-pyridines
03/20/2003CA2459359A1 Pyrazolyl-substituted thienyloxypyridines
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003CA2453259A1 Herbicidal n-alkylsulfonamino derivatives
03/19/2003EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/19/2003EP1293503A1 Triazole derivatives
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292309A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
03/19/2003EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403453A Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534509 Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation
03/18/2003US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
03/18/2003US6534447 Herbicidal pyridine compounds
03/18/2003US6534445 Substituted pyridine herbicides
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 523